Healthier Markets. Healthier Lives.

Innovative finance for affordable and accessible healthcare

We are a social finance company with a difference. We are motivated by purpose, not profit.

Using innovative finance tools, we secure lower prices and sustainable supply of medical products for people in low- and middle-income countries. Our work combines commercial insight and rigour with a relentless pursuit of health impact.

MedAccess is an independent company, wholly owned by the UK’s CDC Group plc.

Front cover of the annual report showing a lady on a bike

OUR IMPACT

Read our 2019 Annual Report

Find out more about MedAccess partnerships and how they are increasing access to innovative healthcare products.

Download Now

Two scientists using a Hologic Panther machine

ABOUT US

Who we are

We believe in a world where everyone can access the medicines and healthcare products they need to lead healthy lives.

Learn more

OUR WORK

Innovative finance for development

Our innovative finance tools enable manufacturers and procurers to enter into partnerships that increase access to medical products for people who need them.

Learn more

Latest News & Insight

News – 31 Mar '21

MedAccess announces extension to guarantee support for UNICEF

Extension will support UNICEF's work to accelerate access to essential supplies for countries around the world

News – 25 Feb '21

COVID-19 vaccine rollout begins in Ghana using syringes purchased with MedAccess support

Ghana will begin its COVID-19 immunisation campaign using syringes provided through MedAccess' support for UNICEF.

Insight – 30 Nov '20

Viral load testing: the key to tackling the HIV epidemic

Through the Global Access Initiative, we are helping to increase access viral load testing through the Panther platform. Ahead of World AIDS Day 2020, two laboratory technicians in Kenya and Zambia told us how Panther is helping them to better serve patients.

Insight – 13 Nov '20

Michael Anderson joins ODI panel on development finance institutions and healthcare

Michael joined an ODI panel to assess the immediate development finance institutions' (DFI) response to the COVID-19 pandemic and how DFI’s could support public sector investment in the health sector.